Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine
Progression‐free survival · people with metastatic breast cancer
Capecitabine‐containing regimens probably leads to lower progression‐free survival (PFS)median compared with chemotherapy regimens without capecitabine (moderate certainty).
1 finding from 1 review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes onlyHR 0.89 [0.83, 0.96]12 studies · 4325 participantsModerate